Skip to main content
. 2022 Nov 1;26(11):832–840. doi: 10.5152/AnatolJCardiol.2022.1934

Figure 1.

Figure 1.

A total of 246 patients with type 2 diabetes mellitus (T2DM) met the inclusion criteria and underwent cardiovascular reflex tests (CARTs). Of these, 114 had definite or confirmed cardiac autonomic neuropathy (CAN) and were included in the study. Sixteen patients in the dapagliflozin group and 18 patients in the control group were excluded due to exclusion criteria. The remaining 80 patients (42 in the dapagliflozin group and 38 in the control group) completed 24-week study period. PVBs, premature ventricular beats.